Compounder Olympia Pharmaceuticals eyes peptide opportunity

An FDA committee will meet next month to discuss lifting a ban on a number of peptides marketed for wellness. Compounding pharmacies have been gearing up for the moment. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure…

Source: Endpoints News